There was no significant difference between HT (27.8%) and HC (30.0%) regarding frequency of individuals positive for CMV-specific IgG (Table 1). One HT patient and three HC were concomitantly ...

“We are pleased with these positive outcomes of the initial preclinical studies in our CMV vaccine program, demonstrating our AI-Immunology™ platform’s ability to identify novel antigens to ...

About cytomegalovirus (CMV) About 1 in 200 babies is born with congenital CMV infection. About 1 in 5 babies with the infection will have congenital disabilities or other long-term health problems.

Difference between HT and HC in the CMV-positive or CMV-negative groups: *** p < 0.01, ** p < 0.02, * p < 0.05. Difference between CMV-positive and CMV-negative individuals in the HC or HT groups ...

No approved CMV vaccine exists today COPENHAGEN, Denmark, November 12, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion&CloseCurlyDoubleQuote;), a clinical-stage TechBio company specializing in ...

No approved CMV vaccine exists today COPENHAGEN, Denmark, November 12, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ ...